Format

Send to

Choose Destination
Vaccine. 2010 Nov 23;28(50):7933-8. doi: 10.1016/j.vaccine.2010.09.074. Epub 2010 Oct 12.

Herpes zoster: Burden of disease in France.

Author information

1
INSERM, U707, F-75012 Paris, France. chiappe@u707.jussieu.fr

Abstract

This work provides estimates of HZ incidence and HZ-related hospitalization and mortality rates in France, where no immunization programme has been implemented. Herpes zoster data was obtained from the Sentinelles surveillance general practitioners (GPs) network, the PMSI Data processing centre for hospital discharges and from the French National Mortality Database (INSERM CépiDC). The yearly HZ incidence rate averaged 382 cases per 100,000 inhabitants (95% CI 364-405) and exponentially increased with age. The annual rates of hospitalizations and mortality due to HZ varied from 4.14±0.32 to 14.42±0.39 and from 0.11±0.03 to 0.29±0.04 per 100,000 inhabitants, respectively, depending on whether HZ was coded in a 'primary' or 'primary or associated' diagnosis. One or more factors of immunodepression occurred in 43.4% of hospitalized cases and in 21.6% HZ-related deaths.

PMID:
20946861
DOI:
10.1016/j.vaccine.2010.09.074
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science Icon for HAL archives ouvertes
Loading ...
Support Center